Merck (MRK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Merck Revenue Highlights

Latest Revenue (Y)

$65.01B

Latest Revenue (Q)

$17.28B

Main Segment (Y)

Pharmaceutical segment

Main Geography (Y)

UNITED STATES

Merck Revenue by Period

Merck Revenue by Year

Date	Revenue	Change
2025-12-31	$65.01B	1.31%
2024-12-31	$64.17B	6.74%
2023-12-31	$60.12B	1.40%
2022-12-31	$59.28B	21.72%
2021-12-31	$48.70B	17.31%
2020-12-31	$41.52B	6.13%
2019-12-31	$39.12B	-7.50%
2018-12-31	$42.29B	5.41%
2017-12-31	$40.12B	0.79%
2016-12-31	$39.81B	0.78%
2015-12-31	$39.50B	-6.48%
2014-12-31	$42.24B	-4.08%
2013-12-31	$44.03B	-6.84%
2012-12-31	$47.27B	-1.62%
2011-12-31	$48.05B	4.48%
2010-12-31	$45.99B	67.66%
2009-12-31	$27.43B	15.00%
2008-12-31	$23.85B	-1.44%
2007-12-31	$24.20B	6.90%
2006-12-31	$22.64B	2.84%
2005-12-31	$22.01B	-4.18%
2004-12-31	$22.97B	2.17%
2003-12-31	$22.49B	4.85%
2002-12-31	$21.45B	1.16%
2001-12-31	$21.20B	-47.48%
2000-12-31	$40.36B	23.38%
1999-12-31	$32.71B	21.62%
1998-12-31	$26.90B	13.80%
1997-12-31	$23.64B	19.21%
1996-12-31	$19.83B	18.87%
1995-12-31	$16.68B	11.43%
1994-12-31	$14.97B	42.59%
1993-12-31	$10.50B	-

Merck generated $65.01B in revenue during NA 2025, up 1.31% compared to the previous quarter, and up 156.59% compared to the same period a year ago.

Merck Revenue by Quarter

Date	Revenue	Change
2025-09-30	$17.28B	9.30%
2025-06-30	$15.81B	1.78%
2025-03-31	$15.53B	-0.61%
2024-12-31	$15.62B	-6.20%
2024-09-30	$16.66B	3.38%
2024-06-30	$16.11B	2.14%
2024-03-31	$15.78B	7.83%
2023-12-31	$14.63B	-8.34%
2023-09-30	$15.96B	6.17%
2023-06-30	$15.04B	3.78%
2023-03-31	$14.49B	4.75%
2022-12-31	$13.83B	-7.55%
2022-09-30	$14.96B	2.51%
2022-06-30	$14.59B	-8.23%
2022-03-31	$15.90B	17.60%
2021-12-31	$13.52B	2.79%
2021-09-30	$13.15B	15.37%
2021-06-30	$11.40B	7.29%
2021-03-31	$10.63B	-15.09%
2020-12-31	$12.52B	14.51%
2020-09-30	$10.93B	16.85%
2020-06-30	$9.35B	-22.43%
2020-03-31	$12.06B	1.59%
2019-12-31	$11.87B	-4.27%
2019-09-30	$12.40B	5.42%
2019-06-30	$11.76B	8.73%
2019-03-31	$10.82B	-1.65%
2018-12-31	$11.00B	1.89%
2018-09-30	$10.79B	3.14%
2018-06-30	$10.46B	4.26%
2018-03-31	$10.04B	-3.80%
2017-12-31	$10.43B	1.05%
2017-09-30	$10.32B	3.98%
2017-06-30	$9.93B	5.26%
2017-03-31	$9.43B	-6.73%
2016-12-31	$10.12B	-4.00%
2016-09-30	$10.54B	7.03%
2016-06-30	$9.84B	5.71%
2016-03-31	$9.31B	-8.84%
2015-12-31	$10.21B	1.41%
2015-09-30	$10.07B	2.94%
2015-06-30	$9.79B	3.82%
2015-03-31	$9.43B	-10.08%
2014-12-31	$10.48B	-0.71%
2014-09-30	$10.56B	-3.45%
2014-06-30	$10.93B	6.53%
2014-03-31	$10.26B	-9.33%
2013-12-31	$11.32B	2.61%
2013-09-30	$11.03B	0.20%
2013-06-30	$11.01B	3.18%
2013-03-31	$10.67B	-9.08%
2012-12-31	$11.74B	2.17%
2012-09-30	$11.49B	-6.69%
2012-06-30	$12.31B	4.94%
2012-03-31	$11.73B	-4.58%
2011-12-31	$12.29B	2.26%
2011-09-30	$12.02B	-1.06%
2011-06-30	$12.15B	4.93%
2011-03-31	$11.58B	-4.25%
2010-12-31	$12.09B	8.71%
2010-09-30	$11.13B	-1.95%
2010-06-30	$11.35B	-0.66%
2010-03-31	$11.42B	13.16%
2009-12-31	$10.09B	66.84%
2009-09-30	$6.05B	2.54%
2009-06-30	$5.90B	9.56%
2009-03-31	$5.39B	-10.73%
2008-12-31	$6.03B	1.49%
2008-09-30	$5.94B	-1.78%
2008-06-30	$6.05B	3.95%
2008-03-31	$5.82B	-6.74%
2007-12-31	$6.24B	-

Merck generated $17.28B in revenue during Q3 2025, up 9.30% compared to the previous quarter, and up 107.22% compared to the same period a year ago.

Merck Revenue Breakdown

Merck Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22
Other Segments	$515.00M	$891.00M	-	-
Pharmaceutical segment	$58.14B	$57.40B	$52.01B	-
Animal Health segment	$6.35B	$5.88B	$5.55B	-
Pharmaceutical	-	-	$53.58B	-
Animal Health	-	-	$5.63B	-
Other	-	-	$907.00M	-

Merck's latest annual revenue breakdown by segment (product or service), as of Dec 25: Pharmaceutical segment (89.43%), Animal Health segment (9.77%), and Other Segments (0.79%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Other Segments	$52.00M	$50.00M	$110.00M	$303.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pharmaceutical segment	$14.84B	$15.61B	$14.05B	$13.64B	$14.04B	$14.94B	$14.41B	$14.01B	$14.26B	$13.46B	$12.72B	$12.18B	$12.96B	$12.76B	$14.11B	$12.04B	$11.50B	$9.98B	$10.68B	$11.37B
Animal Health segment	$1.50B	$1.61B	$1.65B	$1.59B	$1.40B	$1.49B	$1.48B	$1.51B	$1.40B	$1.46B	$1.49B	$1.23B	$1.37B	$1.47B	$1.48B	$1.26B	$1.42B	$1.47B	$1.42B	$1.17B

Merck's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Pharmaceutical segment (90.51%), Animal Health segment (9.18%), and Other Segments (0.32%).

Merck Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22
Latin America	$3.41B	$3.46B	$3.09B	$2.58B
UNITED STATES	$36.51B	$32.28B	$27.21B	-
Asia Pacific	$2.98B	$3.06B	$3.23B	$3.61B
CHINA	$1.94B	$5.49B	$5.19B	-
EMEA	$14.58B	$14.04B	$14.49B	-
JAPAN	$2.71B	$3.28B	$3.63B	-
International	$2.88B	$2.56B	-	-
United States	-	-	$28.48B	-
China	-	-	$6.80B	-
Japan	-	-	$3.16B	-
Other	-	-	$2.10B	-
Europe, Middle East and Africa	-	-	$13.25B	-
Other Countries	-	-	-	-

Merck's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (56.16%), EMEA (22.43%), Latin America (5.25%), Asia Pacific (4.59%), International (4.43%), JAPAN (4.17%), and CHINA (2.98%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
JAPAN	$704.00M	$712.00M	$626.00M	$669.00M	$821.00M	$1.08B	$675.00M	$758.00M	$853.00M	$673.00M	$1.11B	$989.00M	$797.00M	$638.00M	$661.00M	$730.00M	$870.00M	-	-	-
UNITED STATES	$9.14B	$10.01B	$8.84B	$8.52B	$8.19B	$8.74B	$7.88B	$7.48B	$7.71B	$7.02B	$6.66B	$6.28B	$7.32B	$6.24B	$7.34B	$6.26B	$6.28B	$5.10B	$5.14B	$5.63B
International	$784.00M	$798.00M	$595.00M	$701.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Latin America	$854.00M	$905.00M	$859.00M	$792.00M	$869.00M	$936.00M	$858.00M	$796.00M	$895.00M	$742.00M	$661.00M	$649.00M	$684.00M	$642.00M	$607.00M	$575.00M	$599.00M	$532.00M	$569.00M	$604.00M
EMEA	$3.79B	$3.68B	$3.66B	$3.45B	$3.38B	$3.58B	$3.52B	$3.56B	$3.33B	$3.35B	$3.30B	$3.27B	$3.29B	$3.58B	$4.36B	$3.43B	$3.34B	$3.33B	$3.73B	$3.54B
CHINA	$386.00M	$405.00M	$446.00M	$702.00M	$1.77B	$1.69B	$1.91B	$1.72B	$1.23B	$1.44B	$1.37B	$1.14B	$1.37B	$1.31B	$975.00M	$927.00M	$909.00M	-	-	-
Asia Pacific	$745.00M	$764.00M	$785.00M	$689.00M	$2.49B	$2.78B	$3.25B	$3.32B	$781.00M	$848.00M	$846.00M	$822.00M	$854.00M	$1.01B	$930.00M	$625.00M	$613.00M	$594.00M	$751.00M	$735.00M
Other Countries	-	-	-	-	-	-	-	$621.00M	$469.00M	$491.00M	$545.00M	$728.00M	$698.00M	$637.00M	$534.00M	$462.00M	$379.00M	$207.00M	$238.00M	$225.00M

Merck's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (55.73%), EMEA (23.09%), Latin America (5.21%), International (4.78%), Asia Pacific (4.54%), JAPAN (4.29%), and CHINA (2.35%).

Merck Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
NVO	Novo Nordisk	$232.26B	$65.35B
MRK	Merck	$65.01B	$17.28B
PFE	Pfizer	$62.58B	$16.65B
AZN	AstraZeneca	$54.07B	$15.19B
NVS	Novartis	$46.66B	$11.83B
TMO	Thermo Fisher Scientific	$44.56B	$11.12B
ABT	Abbott Laboratories	$44.33B	$11.37B
SNY	Sanofi	$43.07B	$11.12B
AMGN	Amgen	$36.75B	$9.56B
GSK	GSK	$30.33B	$7.36B
GILD	Gilead Sciences	$29.44B	$7.77B

MRK Revenue FAQ

What is Merck’s yearly revenue?

Merck's yearly revenue for 2025 was $65.01B, representing an increase of 1.31% compared to 2024. The company's yearly revenue for 2024 was $64.17B, representing an increase of 6.74% compared to 2023. MRK's yearly revenue for 2023 was $60.12B, representing an increase of 1.40% compared to 2022.

What is Merck’s quarterly revenue?

Merck's quarterly revenue for Q3 2025 was $17.28B, a 9.30% increase from the previous quarter (Q2 2025), and a 3.72% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $15.81B, a 1.78% increase from the previous quarter (Q1 2025), and a -1.90% decrease year-over-year (Q2 2024). MRK's quarterly revenue for Q1 2025 was $15.53B, a -0.61% decrease from the previous quarter (Q4 2024), and a -1.56% decrease year-over-year (Q1 2024).

What is Merck’s revenue growth rate?

Merck's revenue growth rate for the last 3 years (2023-2025) was 8.14%, and for the last 5 years (2021-2025) was 33.48%.

What are Merck’s revenue streams?

Merck's revenue streams in c 25 are Other Segments, Pharmaceutical segment, and Animal Health segment. Other Segments generated $515M in revenue, accounting 0.79% of the company's total revenue, down -42.20% year-over-year. Pharmaceutical segment generated $58.14B in revenue, accounting 89.43% of the company's total revenue, up 1.29% year-over-year. Animal Health segment generated $6.35B in revenue, accounting 9.77% of the company's total revenue, up 8.12% year-over-year.

What is Merck’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Merck was Pharmaceutical segment. This segment made a revenue of $58.14B, representing 89.43% of the company's total revenue.